<?xml version="1.0" encoding="UTF-8"?>
<ref id="R61">
 <label>61.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Khanna</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Furst</surname>
    <given-names>DE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Allanore</surname>
    <given-names>Y</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards</article-title>. 
  <source>Rheumatology</source>
  <year>2015</year>;
  <volume>54</volume>
  <pub-id pub-id-type="doi">10.1093/rheumatology/keu288</pub-id>
 </mixed-citation>
</ref>
